Paweł Różanowski
Impact in
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- Cancer Diagnosis and Treatment
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 3
- Co-authors
- Dawid Sigorski (3 shared papers)Mirosława Püsküllüoğlu (1 shared paper)Michał Jarząb (1 shared paper)Barbara Jarząb (1 shared paper)Waldemar Placek (1 shared paper)Kamil Fijorek (1 shared paper)Lidia Rudnicka (1 shared paper)Ewa Iżycka‐Świeszewska (1 shared paper)
- Journals
- Targeted Oncology (1 paper)Współczesna Onkologia (1 paper)Dermatology Review (1 paper)Oncology in Clinical Practice (1 paper)Nowotwory Journal of Oncology (1 paper)
- Partner nations
- PolandSouth KoreaCzechia
In The Last Decade
Paweł Różanowski
6 papers receiving 22 citations
Peers
Comparison fields: 5 of 21
- Oncology 10
- Radiology, Nuclear Medicine and Imaging 7
- Complementary and alternative medicine 2
- Health Information Management 1
- Pathology and Forensic Medicine 3
Countries citing papers authored by Paweł Różanowski
This map shows the geographic impact of Paweł Różanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Różanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Różanowski more than expected).
Fields of papers citing papers by Paweł Różanowski
This network shows the impact of papers produced by Paweł Różanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Różanowski. The network helps show where Paweł Różanowski may publish in the future.
Co-authors
The 23 scholars most cited alongside Paweł Różanowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Optimization of the method of RNA isolation from paraffin blocks to assess gene expression in breast cancer. | 2008 | 7 |
| 2 | 2017 | 5 | |
| 3 | 2022 | 4 | |
| 4 | 2013 | 4 | |
| 5 | 2019 | 1 | |
| 6 | 2019 | 1 | |
| 7 | Ocena wartości prognostycznej i predykcyjnej 21 genowego wskaźnika ryzyka nawrotu nowotworu (recurrence score) we wczesnym raku piersi. Doniesienie wstępne | 2010 | 0 |
About Paweł Różanowski
Paweł Różanowski is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 7 papers that have together received 22 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper), Prostate Cancer Treatment and Research (1 paper), Nonmelanoma Skin Cancer Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Oncology (10 citations), Radiology, Nuclear Medicine and Imaging (7 citations), Complementary and alternative medicine (2 citations), Health Information Management (1 citation) and Pathology and Forensic Medicine (3 citations). Paweł Różanowski has collaborated with scholars based in Poland, South Korea and Czechia. Frequent co-authors include Dawid Sigorski, Mirosława Püsküllüoğlu, Michał Jarząb, Barbara Jarząb, Waldemar Placek, Kamil Fijorek, Lidia Rudnicka, Ewa Iżycka‐Świeszewska, Katarzyna Wiktorska and Krzysztof Okoń. Their work appears in journals such as Targeted Oncology, Współczesna Onkologia, Dermatology Review, Oncology in Clinical Practice and Nowotwory Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.